Voiding Dysfunction

Minimally invasive treatments grab BPH spotlight

January 30, 2019

Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.

TURP duration linked with complication rate

November 20, 2018

Procedure safest when performed in

OAB patients continue medical therapy unnecessarily

November 20, 2018

A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.

Nearly 30% of U.S. women report nocturia

November 20, 2018

Nocturia appears to be highly prevalent in the United States, with almost 30% of all women reporting significant nocturia, according to new data reported at the AUA annual meeting in San Francisco.

Data shift thinking on nocturia’s causes, treatment

November 20, 2018

 Waking up at night to urinate is by far the most bothersome lower urinary tract symptom. 

BPH procedures and med use: Two sides of a coin

November 14, 2018

"When analyzing efficacy of minimally invasive/surgical therapies for lower urinary tract symptoms secondary to BPH, we appropriately focus on subjective criteria and objective criteria. While we discuss retreatment rates, we don’t measure failure of therapies by how many men restart LUTS/BPH medications," writes Steven A. Kaplan, MD.

Which BPH procedures best reduce need for meds?

November 14, 2018

Tissue-eliminating procedures outperform tissue-necrosing procedures for reducing the need for medication in patients with benign prostatic enlargement, researchers say.

Non-head MRI found safe in patients undergoing SNM

November 07, 2018

The therapeutic efficacy of sacral neuromodulation was not affected by non-head magnetic resonance imaging scans in a recent study.